SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending as the community eagerly anticipates FDA approval for its Galleri multi-cancer early detection test following a recent PMA submission and positive PATHFINDER 2 study results, with strategic partnerships and legislative progress on Medicare reimbursement further fueling excitement about its disruptive, life-saving potential.

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy is actively discussed amidst news surrounding its upcoming on-chain real estate sale in Hawaii and an ambitious 2025 roadmap detailing AI integration and market expansion in the real-world asset (RWA) sector. While many anticipate significant long-term growth for real estate tokenization, community sentiment is divided on its short-term price action and market dynamics.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is currently trending as the community eagerly anticipates imminent PMDA approval in Japan and celebrates successful glioblastoma patient treatment updates, fueling strong bullish sentiment and institutional accumulation for its Alpha DaRT oncology technology.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

ShapeShift FOX Token (FOX) is trending amidst intense community debate, with bullish proponents citing technical indicators and its low market cap as precursors to a massive 'alt season' breakout, while a vocal segment continues to label it a persistent pump-and-dump.

Bridgford Foods Corp. engages in the manufacture, market, and distribution of frozen and snack food products. It operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment manufactures and distributes food products, including biscuits, bread dough items, roll dough items, and sandwiches. The Snack Food Products segment distributes both products manufactured by the company and third parties. The company was founded by Hugh H. Bridgford in February 1932 and is headquartered in Dallas, TX.

Bridgford Foods Corp.

Bridgford Foods Corporation

Bridgford Foods (BRID) is trending as the community speculates on potential gross margin boosts from increased beef imports and the company's aggressive expansion into private-label offerings with major retailers, positioning it as an undervalued defensive play.

Direxion Shares ETF Trust - Direxion Daily South Korea Bull 3X Shares

Direxion Daily South Korea Bull 3X Shares

Direxion Daily South Korea Bull 3X Shares ($KORU) is experiencing a massive surge following South Korea's recent ban on short selling, intensifying its already impressive year-to-date rally fueled by semiconductor giants like Samsung and SK Hynix in the booming memory market.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

Community discussion is intensely focused on claims linking Bitcoin to alleged illicit activities and the fallout from recent file releases, fueling a pervasive narrative that Bitcoin is a "scam" or "pedo-currency." This strong bearish sentiment is driving significant interest in $BITI, as many anticipate a market collapse for Bitcoin and seek to capitalize on its potential decline.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

Hapag-Lloyd's $35-per-share cash acquisition offer is driving intense conversation around ZIM Integrated Shipping, with the community actively discussing the deal's complex regulatory approvals, potential for a short squeeze, and the implications for future dividend payouts given the company's strong cash position.

Garmin Ltd. is a holding company, which engages in the provision of navigation, communications and information devices, most of which are enabled by Global Positioning System (GPS) technology. It operates through the following segments: Marine, Outdoor, Fitness, Auto OEM, Consumer Auto, and Aviation. The Marine segment manufactures and offers recreational marine electronics such as cartography, Sounders, Radar, Autopilot Systems and Sailing. The Outdoor segment offers products designed for use in outdoor activities such as Outdoor Handhelds, Adventure Watches, Golf Devices, Dog Tracking & Training Device, Garmin Connect & Garmin Connect Mobile, and Connect IQ. The Fitness segment refers to the products designed for use in fitness and activity tracking such as Running & Multi-Sport Watches, Cycling Computers, Power Meters, Safety & Awareness, and Activity Tracking Devices. The Auto OEM and Consumer Auto segments offer products designed for use in the auto market such as Personal Navigation Devices, Original Equipment Manufacturer (OEM) Solutions, and Cameras. The Aviation segment provides solutions to aircraft manufacturers, existing aircraft owners and operators, as well as government/defense customers. The company was founded in 1989 and is headquartered in Schaffhausen, Switzerland.

Garmin Ltd

Garmin is actively discussed after reporting exceptional earnings that exceeded expectations, bolstering investor confidence and drawing attention to its strong leadership in diverse sectors like fitness, marine, and automotive, alongside strategic innovations and collaborations.

Talus is an AI infrastructure network that provides an on-chain execution layer for autonomous and intelligent agents. The project develops Nexus, a decentralized automation protocol, to enable AI agents to execute complex workflows in a verifiable manner on-chain, fostering a transparent and trustless environment for AI and consumer use cases. Ultimately, Talus is building the core infrastructure for decentralized AI agents, allowing developers to launch revenue-generating agents. By leveraging the Sui network to bridge off-chain AI compute with on-chain execution, Talus establishes the foundational layer for the AI and Information Economy.

UltraSolid

UltraSolid (Talus token) is generating significant buzz within the crypto community, with strong bullish sentiment driving discussions about accumulating dips and predictions of substantial price movements, despite some concerns about potential manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Olema Pharmaceuticals CEO Teases Fall OPERA-01 Readout, Q2 KAT6 Data and CFO/COO Exit

Olema Pharmaceuticals (NASDAQ:OLMA) is focused on developing endocrine therapies aimed at improving outcomes for patients with estrogen receptor (ER)-positive, HER2-negative breast cancer, CEO Sean...

This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Analysts at Stifel Nicolaus

Stifel Nicolaus assumed coverage on Olema Pharmaceuticals in a research report on Wednesday. They set a "buy" rating and a $48.00 price target for the company...

Candriam S.C.A. Increases Stock Position in Olema Pharmaceuticals, Inc. $OLMA

Candriam S.C.A. raised its stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 46.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Rating of "Moderate Buy" by Analysts

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) has been given an average rating of "Moderate Buy" by the ten brokerages that are currently covering the company, MarketBeat reports. One...

Short Interest in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Decreases By 12.5%

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totaling 9,100,561 shares...

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% Higher - Here's What Happened

Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 7.7% - Here's Why...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 10,000 Shares

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of Olema Pharmaceuticals stock in a transaction on Tuesday, January 20th. The stock was sold at an...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 10,000 Shares

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, January 20th. The shares were sold...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells $101,599.68 in Stock

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 3,489 shares of the business's stock in a transaction on Wednesday, January 14th. The stock was sold at an...

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$22.59
Prev Close	$23.75
Open	$23.66
Dividend Yield	0.00%
50-Day Moving Average	$27.11
Beta	1.00
Avg. Volume	1.2M
PE Ratio	-12.47

52-Week High	$36.26
52-Week Low	$2.86
Market Capitalization	$1.78B
EPS (Annual)	-$2.20
Price to Book	5.04
Revenue Per Employee	$0.00

OLMA
Olema Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OLMA News

OLMAOlema Pharmaceuticals Inc